Related Experiment Videos
Hepatitis C: screening in pregnancy.
1Pediatric, Adolescent and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institutes of Child Health and Human Development, Bethesda, Maryland, USA.
Obstetrics and Gynecology
|November 27, 1999
Summary
Hepatitis C virus (HCV) infection poses significant health risks. Selective prenatal screening for HCV in pregnant women with risk factors is recommended to prevent transmission to infants.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) infection is more common than HIV and can cause severe liver disease, including cirrhosis, liver cancer, and death.
- HCV shares transmission routes with HIV (parenteral, sexual, mother-to-infant).
- Recent guidelines recommend screening infants born to HCV-infected mothers or those with risk factors.
Purpose of the Study:
- To evaluate the necessity and feasibility of prenatal screening for Hepatitis C virus.
- To determine the optimal strategy for identifying pregnant women with HCV.
Main Methods:
- Review of current literature on HCV prevalence, transmission, and screening guidelines.
- Analysis of recommendations from the American Academy of Pediatrics and CDC.
- Assessment of the asymptomatic nature of most HCV infections in women.
Main Results:
- HCV infection leads to serious health consequences, similar to HIV.
- Most infected women are asymptomatic, highlighting the need for effective screening.
- Current data do not support universal prenatal HCV testing.
Conclusions:
- Selective prenatal screening for Hepatitis C virus based on identified risk factors is warranted.
- Obstetricians should implement risk-based HCV testing for pregnant patients.
- Further research may inform future universal screening recommendations.